Summary

The global top 10 Medical Device Technologies market is projected to reach USD 577.5 billion by 2027
from USD 437.4 billion in 2022, at a CAGR of 5.7% during the forecast period. Globally, with the rapid growth in aging population, the incidence of a number of chronic diseases is on the rise. Moreover, the elderly is more susceptible to traumas and injuries. Due to these factors, the demand for advanced medical equipment is increasing across the globe.

The emerging markets in Asia-Pacific (India and China) and Latin America (Brazil and Mexico) are expected to offer significant growth opportunities in the coming years. The high growth in these markets can majorly be attributed to the rising geriatric population; growing prevalence of chronic diseases; improving healthcare infrastructure due to increasing investments by respective government bodies; and rising investments by leading players in these countries.

“The Cardiology Devices Market segment holds the second largest share in top 10 Medical Device Technologies market.”
The growth in the Cardiology Devices Market is mainly driven by the increasing incidences of cardiovascular diseases and launch of innovative products by market players. However, low affordability and inaccessibility of cardiac surgeries in developing countries is expected to restrain the growth of cardiology devices market during the forecast period.

“In the forecast period, global respiratory care & anesthesia devices market segment is expected to grow at the highest CAGR in the top 10 medical devices market”
During the forecast period, the global respiratory care & anesthesia devices segment is expected to grow at the highest CAGR. The increasing need for advanced and innovative machines and equipment and high incidence of chronic obstructive pulmonary diseases (COPD) and obtrusive sleep apnea (OSA) are key factors driving the growth of this market. The changing preference of patients towards home care devices is expected to propel the growth of anesthesia and respiratory care devices market.

“By Region, Europe holds the second largest share in the top 10 Medical Device Technologies market, in the forecast period”
By Region, In 2021, Europe accounted for the second largest share of the top 10 Medical Device Technologies market in the forecast period, followed by the Asia Pacific, Latin America, and the Middle East & Africa. This is mainly attributed to the demand for advanced Medical Device Technologies and the presence of leading players in this region. Factors such as the Eurozone debt crisis and uncertainty and variations in reimbursement across the region may hamper the growth of this market to a certain extent.

A breakdown of the primary participants for the top 10 Medical Device Technologies market referred to for this report is provided below:
• By Company Type: Tier 1–35%, Tier 2–45%, and Tier 3–20%
• By Designation: C-level–35%, Director Level–25%, and Others–40%
• By Region: North America–40%, Asia- Pacific–30%, Europe–20%, Middle East & Africa–5%, Latin America- 5%

The prominent players in the global top 10 Medical Device Technologies market are Abbott Laboratories, Inc. (US), Roche Diagnostics (Switzerland), Koninklijke Philips N.V. (Netherlands), Siemens Healthineers (Germany), Stryker Corporation (US), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic PLC (Ireland), Smith & Nephew PLC (UK), GE Healthcare (US).

Research Coverage:
This research report categorizes the top 10 Medical Device Technologies market by type and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the top 10 Medical Device Technologies market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the top 10 Medical Device Technologies market. Competitive analysis of upcoming startups in the top 10 Medical Device Technologies market ecosystem is covered in this report.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall top 10 Medical Device Technologies market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights on the following pointers:
• Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global top 10 Medical Device Technologies market
• Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product or service launches in the global top 10 Medical Device Technologies market
• Market Development: Comprehensive information on the lucrative emerging regions by type and region
• Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global top 10 Medical Device Technologies market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis, and products of leading players in the global top 10 Medical Device Technologies market.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 52
1.1 STUDY OBJECTIVES 52
1.2 MARKET DEFINITION 52
1.2.1 INCLUSIONS AND EXCLUSIONS 53
1.3 MARKET SCOPE 53
1.3.1 MARKETS COVERED 53
FIGURE 1 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET 54
1.3.2 REGIONAL SCOPE 54
1.3.3 YEARS CONSIDERED 55
1.4 CURRENCY CONSIDERED 55
TABLE 1 STANDARD CURRENCY CONVERSION RATES 55
1.5 LIMITATIONS 55
1.6 STAKEHOLDERS 56
1.7 RECESSION IMPACT 56
2 RESEARCH METHODOLOGY 57
2.1 RESEARCH DATA 57
FIGURE 2 RESEARCH DESIGN 57
2.1.1 SECONDARY DATA 58
2.1.1.1 Key data from secondary sources 59
2.1.2 PRIMARY DATA 59
FIGURE 3 PRIMARY SOURCES 59
2.1.2.1 Key data from primary sources 60
2.1.2.2 Key industry insights 61
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 61
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 62
2.2 MARKET SIZE ESTIMATION 62
FIGURE 6 BOTTOM-UP APPROACH 63
FIGURE 7 TOP-DOWN APPROACH 63
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027) 64
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 65
FIGURE 9 DATA TRIANGULATION METHODOLOGY 65
2.4 MARKET SHARE ESTIMATION 66
2.5 STUDY ASSUMPTIONS 66
2.6 METHODOLOGY-RELATED LIMITATIONS 66
2.7 RISK ASSESSMENT 67
TABLE 2 RISK ASSESSMENT: TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET 67
2.8 IMPACT OF RECESSION ON TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET 67
3 EXECUTIVE SUMMARY 68
FIGURE 10 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY TYPE, 2022–2027 68
FIGURE 11 RESPIRATORY CARE AND ANESTHESIA DEVICES SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD 69
FIGURE 12 IN VITRO DIAGNOSTICS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 70
FIGURE 13 CARDIOLOGY DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 70
FIGURE 14 OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 71
FIGURE 15 ENDOSCOPY DEVICES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 72
FIGURE 16 GEOGRAPHIC SNAPSHOT OF TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET 72
4 PREMIUM INSIGHTS 74
4.1 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET OVERVIEW 74
FIGURE 17 INCREASING INCIDENCE OF CHRONIC DISEASES TO DRIVE MARKET 74
4.2 10 MEDICAL DEVICE TECHNOLOGIES MARKET: GROWTH OPPORTUNITIES, BY COUNTRY 75
FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 75
4.3 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET, BY REGION (2020–2027) 76
FIGURE 19 NORTH AMERICA WILL CONTINUE TO DOMINATE TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET IN 2027 76
4.4 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 76
FIGURE 20 DEVELOPING COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 76
5 MARKET OVERVIEW 77
5.1 INTRODUCTION 77
5.2 MARKET DYNAMICS 77
FIGURE 21 TOP 10 MEDICAL DEVICE TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 77
5.2.1 DRIVERS 78
5.2.1.1 Rising prevalence of chronic diseases and related increase in disability-adjusted life years 78
TABLE 3 PROJECTED DISABILITY-ADJUSTED LIFE YEARS ACROSS VARIOUS REGIONS, BY CAUSE, 2015 VS. 2030 (MILLION YEARS) 78
TABLE 4 GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65 YEARS AND OVER), 2020 VS. 2040 79
5.2.1.2 Technological advancements in medical devices 79
5.2.1.3 Rapidly increasing geriatric population 80
FIGURE 22 SHARE OF GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 80
5.2.2 RESTRAINTS 80
5.2.2.1 Uncertainty in reimbursement 80
5.2.2.2 Excise tax on medical devices in US 81
5.2.3 OPPORTUNITIES 82
5.2.3.1 Increasing investments from government bodies and private players in healthcare sectors in emerging economies 82
5.2.3.2 Increasing focus of key players on medical devices market in emerging countries 82
5.2.4 CHALLENGES 83
5.2.4.1 High cost of medical devices and implants 83
5.2.4.2 Hospital budget cuts 83
5.2.4.3 Increasing adoption of refurbished medical devices 83
6 IN VITRO DIAGNOSTICS MARKET 85
6.1 INTRODUCTION 86
6.2 MARKET DYNAMICS 86
FIGURE 23 IN VITRO DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 86
6.2.1 DRIVERS 87
6.2.1.1 Gradual shift from centralized testing to point-of-care testing 87
6.2.1.2 Growing awareness of early disease diagnosis in emerging economies 87
6.2.1.3 Emergence of rapid PoC diagnostics and rising adoption of automated analyzers 88
TABLE 5 IN VITRO DIAGNOSTICS MARKET: PRODUCT LAUNCHES (2020−2022) 88
6.2.2 RESTRAINTS 89
6.2.2.1 Unfavorable reimbursement scenario 89
6.2.3 OPPORTUNITIES 89
6.2.3.1 Introduction of disease-specific biomarkers and tests 89
TABLE 6 APPLICATION OF CANCER BIOMARKERS IN CLINICAL PRACTICE 90
6.2.3.2 Growing significance of companion diagnostics 90
6.2.4 CHALLENGES 91
6.2.4.1 Stringent regulatory and legal guidelines 91
FIGURE 24 IVDR: KEY AREAS OF IMPACT 91
TABLE 7 IVD MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 92
TABLE 8 IVD MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 93
6.3 IMMUNOASSAY/IMMUNOCHEMISTRY 93
6.3.1 RISING TREND OF AUTOMATION TO DRIVE MARKET 93
TABLE 9 KEY IMMUNOASSAY/IMMUNOCHEMISTRY ANALYZERS AVAILABLE IN IVD MARKET 94
TABLE 10 IMMUNOASSAY/IMMUNOCHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
6.4 CLINICAL CHEMISTRY 95
6.4.1 INCREASING INCIDENCE OF LIFESTYLE DISEASES TO PROPEL MARKET 95
TABLE 11 CLINICAL CHEMISTRY ANALYZERS FOR HIGH AND MID-VOLUME LABORATORIES 96
TABLE 12 CLINICAL CHEMISTRY ANALYZERS FOR LOW-VOLUME LABORATORIES 97
TABLE 13 CLINICAL CHEMISTRY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 98
6.5 MOLECULAR DIAGNOSTICS 98
6.5.1 RISING PREVALENCE OF INFECTIOUS DISEASES TO SUPPORT MARKET GROWTH 98
TABLE 14 KEY AUTOMATED MOLECULAR DIAGNOSTIC PLATFORMS AVAILABLE IN IVD MARKET 99
TABLE 15 MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 100
6.6 HEMATOLOGY 100
6.6.1 INCREASING ADOPTION OF AUTOMATED HEMATOLOGY ANALYZERS TO DRIVE MARKET 100
TABLE 16 KEY HEMATOLOGY ANALYZERS AVAILABLE IN IVD MARKET 101
TABLE 17 HEMATOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 102
6.7 MICROBIOLOGY 102
6.7.1 RISING PREVALENCE OF MICROBIAL INFECTIONS TO DRIVE MARKET 102
TABLE 18 KEY MICROBIOLOGY INSTRUMENTS AVAILABLE IN IVD MARKET 103
TABLE 19 MICROBIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 104
6.8 COAGULATION AND HEMOSTASIS 104
6.8.1 GROWING USE OF ANTICOAGULATION THERAPY IN SURGICAL PROCEDURES TO DRIVE MARKET 104
TABLE 20 KEY COAGULATION ANALYZERS AVAILABLE IN IVD MARKET 105
TABLE 21 KEY POINT-OF-CARE/SELF-MONITORING COAGULATION ANALYZERS AVAILABLE IN IVD MARKET 106
TABLE 22 COAGULATION AND HEMOSTASIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 106
6.9 URINALYSIS 107
6.9.1 RISING PREVALENCE OF KIDNEY DISORDERS AND UTIS TO SUPPORT MARKET GROWTH 107
TABLE 23 KEY URINALYSIS INSTRUMENTS AVAILABLE IN IVD MARKET 107
TABLE 24 URINALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 108
6.10 OTHER IVD TECHNOLOGIES 108
TABLE 25 KEY BLOOD GLUCOSE TESTING SYSTEMS AVAILABLE IN IVD MARKET 109
TABLE 26 TISSUE PROCESSORS, EMBEDDERS, MICROTOMES, AND STAINERS AVAILABLE IN IVD MARKET 109
TABLE 27 OTHER IVD TECHNOLOGIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 110
7 CARDIOLOGY DEVICES MARKET 111
7.1 INTRODUCTION 112
7.2 MARKET DYNAMICS 112
FIGURE 25 CARDIOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 112
7.2.1 DRIVERS 113
7.2.1.1 Increasing incidence of cardiovascular diseases 113
7.2.1.2 Launch of innovative products by market players 113
7.2.2 RESTRAINTS 114
7.2.2.1 Low affordability and inaccessibility of cardiac surgeries in developing countries 114
7.2.3 OPPORTUNITIES 114
7.2.3.1 Growth potential of emerging economies 114
7.2.4 CHALLENGES 114
7.2.4.1 Stringent regulatory requirements delaying approval of cardiac devices 114
TABLE 28 CARDIOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 115
TABLE 29 CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 116
7.3 CARDIOVASCULAR MONITORING DEVICES 116
7.3.1 INCREASING ACCEPTANCE OF REMOTE MONITORING DEVICES TO PROPEL MARKET GROWTH 116
TABLE 30 CARDIOVASCULAR MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 117
7.4 CARDIAC RHYTHM MANAGEMENT DEVICES 118
7.4.1 TECHNOLOGICAL IMPROVEMENTS IN PACEMAKERS TO SUPPORT MARKET GROWTH 118
TABLE 31 CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 119
7.5 INTERVENTIONAL CARDIOLOGY DEVICES 119
7.5.1 USED FOR DIAGNOSIS AND TREATMENT OF ARTERIAL BLOCKAGES 119
TABLE 32 INTERVENTIONAL CARDIOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 120
7.6 PERIPHERAL VASCULAR DEVICES 120
7.6.1 EMERGENCE OF ADVANCED FLOW ALTERATION DEVICES TO SUPPORT MARKET GROWTH 120
TABLE 33 PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 121
7.7 PROSTHETIC DEVICES 122
7.7.1 STRINGENT APPROVAL PROCESS TO RESTRAIN MARKET GROWTH 122
TABLE 34 PROSTHETIC DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 122
7.8 ELECTROPHYSIOLOGY DEVICES 123
7.8.1 LACK OF SKILLED AND EXPERIENCED ELECTROPHYSIOLOGISTS TO RESTRAIN MARKET GROWTH 123
TABLE 35 ELECTROPHYSIOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
8 DIAGNOSTIC IMAGING DEVICES MARKET 124
8.1 INTRODUCTION 125
8.2 MARKET DYNAMICS 125
FIGURE 26 DIAGNOSTIC IMAGING DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 125
8.2.1 DRIVERS 126
8.2.1.1 Growing geriatric population and rising prevalence of associated diseases 126
TABLE 36 AGE-RELATED DISEASES AND ASSOCIATED DIAGNOSTIC MODALITIES 126
8.2.1.2 Technological advancements in diagnostic imaging modalities 126
TABLE 37 TECHNOLOGICAL ADVANCEMENTS IN DIAGNOSTIC IMAGING SYSTEMS 127
8.2.2 RESTRAINTS 127
8.2.2.1 High cost of diagnostic imaging systems 127
8.2.3 OPPORTUNITIES 128
8.2.3.1 Adoption of AI and analytics in diagnostic imaging 128
8.2.4 CHALLENGES 129
8.2.4.1 Hospital budget cuts 129
TABLE 38 DIAGNOSTIC IMAGING DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 39 DIAGNOSTIC IMAGING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 130
8.3 ULTRASOUND SYSTEMS 130
8.3.1 TECHNOLOGICAL AND SOFTWARE MODIFICATIONS IN ULTRASOUND TECHNOLOGY TO DRIVE MARKET 130
TABLE 40 ULTRASOUND SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 131
8.4 X-RAY SYSTEMS 132
8.4.1 EASY ACCESSIBILITY AND ADEQUACY OF X-RAY DEVICES TO PROPEL MARKET 132
TABLE 41 X-RAY SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 133
8.5 NUCLEAR IMAGING EQUIPMENT 133
8.5.1 HIGH COST OF NUCLEAR IMAGING EQUIPMENT TO RESTRAIN MARKET GROWTH 133
TABLE 42 NUCLEAR IMAGING EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 134
8.6 MAGNETIC RESONANCE IMAGING (MRI) SYSTEMS 134
8.6.1 SAFETY ISSUES ASSOCIATED TO HAMPER MARKET GROWTH 134
TABLE 43 MAGNETIC RESONANCE IMAGING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 135
8.7 COMPUTED TOMOGRAPHY (CT) SCANNERS 135
8.7.1 GROWING APPLICATIONS OF CT SCANNERS TO DRIVE MARKET 135
TABLE 44 COMPUTED TOMOGRAPHY SCANNERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 136
8.8 MAMMOGRAPHY SYSTEMS 137
8.8.1 MAMMOGRAPHY SYSTEMS SEGMENT TO GROW AT HIGHEST CAGR 137
TABLE 45 MAMMOGRAPHY SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 137
9 ORTHOPEDIC DEVICES MARKET 138
9.1 INTRODUCTION 139
9.2 MARKET DYNAMICS 139
FIGURE 27 ORTHOPEDIC DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 139
9.2.1 DRIVERS 140
9.2.1.1 Increasing prevalence of orthopedic diseases and disorders 140
9.2.1.2 Rising number of sports and accident-related orthopedic injuries 140
9.2.2 RESTRAINTS 141
9.2.2.1 High cost associated with orthopedic treatments 141
9.2.3 OPPORTUNITIES 141
9.2.3.1 Increasing use of robotics and 3D printing in orthopedics 141
9.2.4 CHALLENGES 142
9.2.4.1 Dearth of orthopedic surgeons 142
TABLE 46 ORTHOPEDIC DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 47 ORTHOPEDIC DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 143
9.3 ORTHOBIOLOGICS 144
9.3.1 RISING INCIDENCE OF DEFORMITIES AND TRAUMA IN SMALL EXTREMITIES TO DRIVE MARKET 144
TABLE 48 ORTHOBIOLOGICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 145
9.4 JOINT RECONSTRUCTION DEVICES 145
9.4.1 INCREASING PARTICIPATION IN SPORTS TO BOOST ADOPTION 145
TABLE 49 JOINT RECONSTRUCTION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 146
9.5 SPINAL SURGERY DEVICES 146
9.5.1 INCREASING INCIDENCE OF SPINAL DEFORMITIES TO DRIVE ADOPTION 146
TABLE 50 SPINAL SURGERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 147
9.6 TRAUMA FIXATION PRODUCTS 147
9.6.1 INCREASING INCIDENCE OF OSTEOPOROSIS TO DRIVE MARKET 147
TABLE 51 TRAUMA FIXATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 148
9.7 ARTHROSCOPIC DEVICES 148
9.7.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES TO SUPPORT MARKET GROWTH 148
TABLE 52 ARTHROSCOPIC DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 149
9.8 ORTHOPEDIC ACCESSORIES 149
9.8.1 INCREASING PREVALENCE OF RHEUMATOID DISEASES AND OSTEOARTHRITIS TO PROPEL MARKET 149
TABLE 53 ORTHOPEDIC ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 150
9.9 ORTHOPEDIC BRACES AND SUPPORTS 150
9.9.1 RISING PREVALENCE OF ORTHOPEDIC INJURIES AND DISORDERS TO PROPEL MARKET 150
TABLE 54 ORTHOPEDIC BRACES AND SUPPORTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 151
10 OPHTHALMOLOGY DEVICES MARKET 152
10.1 INTRODUCTION 153
10.2 MARKET DYNAMICS 154
FIGURE 28 OPHTHALMOLOGY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 154
10.2.1 DRIVERS 154
10.2.1.1 Rising prevalence of eye disorders 154
TABLE 55 PREVALENCE OF EYE DISORDERS, BY TYPE, 2021 (IN MILLION) 155
10.2.1.1.1 Cataracts 155
TABLE 56 NUMBER OF CATARACT SURGERIES, BY COUNTRY, 2020 VS. 2021 155
10.2.1.1.2 Glaucoma 155
TABLE 57 NUMBER OF GLAUCOMA PATIENTS, BY REGION AND TYPE, 2020 VS 2040 (IN MILLION) 156
10.2.1.1.3 Obesity and diabetes 156
TABLE 58 NUMBER OF PEOPLE WITH DIABETES, BY REGION, 2030 VS. 2045 (MILLION) 156
10.2.1.1.4 Age-related macular degeneration (AMD) 157
TABLE 59 NUMBER OF PEOPLE WITH AGE-RELATED MACULAR DEGENERATION, BY REGION, 2020 VS. 2050 (MILLION) 157
10.2.1.2 Technological advancements in ophthalmic devices 157
TABLE 60 RECENT PRODUCT LAUNCHES IN OPHTHALMOLOGY DEVICES MARKET (2020–2021) 158
10.2.2 RESTRAINTS 158
10.2.2.1 High cost and risk associated with eye surgeries 158
10.2.3 OPPORTUNITIES 159
10.2.3.1 Low adoption of phacoemulsification devices and premium IOLs in emerging regions 159
10.2.4 CHALLENGES 159
10.2.4.1 Low accessibility to eye care in low-income countries 159
TABLE 61 OPHTHALMOLOGY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 62 OPHTHALMOLOGY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 161
10.3 OPHTHALMIC DIAGNOSTIC AND MONITORING DEVICES 161
10.3.1 INCREASING INCIDENCE AND PREVALENCE OF OPHTHALMIC DISORDERS TO DRIVE MARKET 161
TABLE 63 OPHTHALMIC DIAGNOSTIC AND MONITORING DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 162
10.4 REFRACTIVE SURGERY DEVICES 162
10.4.1 RISING PREVALENCE OF UNCORRECTED REFRACTIVE ERRORS TO SUPPORT MARKET GROWTH 162
TABLE 64 REFRACTIVE SURGERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 163
10.5 GLAUCOMA SURGERY DEVICES 163
10.5.1 RISING GERIATRIC POPULATION TO PROPEL ADOPTION 163
TABLE 65 GLAUCOMA SURGERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 164
10.6 CATARACT SURGERY DEVICES 164
10.6.1 FAVORABLE REIMBURSEMENT POLICIES IN DEVELOPED COUNTRIES TO SUPPORT MARKET GROWTH 164
TABLE 66 CATARACT SURGERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 165
10.7 VITREORETINAL SURGERY DEVICES 166
10.7.1 INCREASING PREVALENCE OF DIABETIC RETINOPATHY AND AMD SURGERY DEVICES TO SUPPORT MARKET GROWTH 166
TABLE 67 VITREORETINAL SURGERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 166
10.8 VISION CARE DEVICES 167
10.8.1 TECHNOLOGICAL ADVANCEMENTS IN LENS MATERIALS TO DRIVE MARKET 167
TABLE 68 VISION CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 167
11 ENDOSCOPY DEVICES MARKET 168
11.1 INTRODUCTION 169
11.2 MARKET DYNAMICS 169
FIGURE 29 ENDOSCOPY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 169
11.2.1 DRIVERS 170
11.2.1.1 Surging requirement for endoscopy to diagnose and treat target diseases 170
FIGURE 30 UK: NUMBER OF ANNUAL PLANNED ENDOSCOPY SESSIONS PER INDIVIDUAL 170
11.2.1.2 Adoption of single-use endoscopy instruments to prevent infectious diseases 171
11.2.2 RESTRAINTS 171
11.2.2.1 High overhead cost of endoscopy procedures with limited reimbursement in developing countries 171
11.2.3 OPPORTUNITIES 172
11.2.3.1 Booming healthcare sector in developing economies 172
11.2.4 CHALLENGES 172
11.2.4.1 Infections caused by some endoscopy products offered by giant companies 172
TABLE 69 ENDOSCOPY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 173
TABLE 70 ENDOSCOPY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 173
11.3 ENDOSCOPES 174
TABLE 71 ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 72 ENDOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 175
11.3.1 RIGID ENDOSCOPES 175
11.3.1.1 Growing demand for minimally invasive surgical procedures to propel market growth 175
TABLE 73 RIGID ENDOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 176
11.3.2 FLEXIBLE ENDOSCOPES 176
11.3.2.1 Rising prevalence of colorectal cancer to support market growth 176
TABLE 74 FLEXIBLE ENDOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 177
11.3.3 ROBOT-ASSISTED ENDOSCOPES 177
11.3.3.1 Technological advancements to support market growth 177
TABLE 75 ROBOT-ASSISTED ENDOSCOPE PRODUCTS 178
TABLE 76 ROBOT-ASSISTED ENDOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 178
11.3.4 DISPOSABLE ENDOSCOPES 179
11.3.4.1 Strong focus on preventing hospital-acquired infections to increase demand 179
TABLE 77 INDICATIVE LIST OF DISPOSABLE ENDOSCOPE MANUFACTURERS 179
TABLE 78 DISPOSABLE ENDOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 180
11.3.5 CAPSULE ENDOSCOPES 180
11.3.5.1 Favorable reimbursement policies to support market growth 180
TABLE 79 INDICATIVE LIST OF CAPSULE ENDOSCOPE MANUFACTURERS 181
TABLE 80 CAPSULE ENDOSCOPES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 182
11.4 VISUALIZATION EQUIPMENT 182
TABLE 81 VISUALIZATION EQUIPMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 82 VISUALIZATION EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 184
11.4.1 WIRELESS DISPLAYS AND MONITORS 184
11.4.1.1 Use of wireless displays and monitors reduces cost of routing cables through ceilings in hospitals 184
TABLE 83 WIRELESS DISPLAYS AND MONITORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 185
11.4.2 ENDOSCOPIC LIGHT SOURCES 185
11.4.2.1 Light sources are critical components of endoscopy visualization systems 185
TABLE 84 ENDOSCOPIC LIGHT SOURCES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 186
11.4.3 VIDEO CONVERTERS 187
11.4.3.1 Need for high-resolution images and videos to propel market 187
TABLE 85 VIDEO CONVERTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 187
11.4.4 VIDEO RECORDERS 188
11.4.4.1 Necessity to document patient data to drive market 188
TABLE 86 VIDEO RECORDERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 188
11.4.5 VIDEO PROCESSORS 189
11.4.5.1 Sort electric signals transmitted by camera head according to pixel location and intensity 189
TABLE 87 VIDEO PROCESSORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 189
11.4.6 CAMERA HEADS 190
11.4.6.1 Technological advancements in camera technology to propel market 190
TABLE 88 CAMERA HEADS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 190
11.4.7 TRANSMITTERS AND RECEIVERS 191
11.4.7.1 Wireless transmitters and receivers ensure operating room safety and efficiency 191
TABLE 89 TRANSMITTERS AND RECEIVERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 191
11.4.8 CARTS 192
11.4.8.1 Surge in demand for endoscopy systems to fuel demand 192
TABLE 90 CARTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 192
11.4.9 OTHER VISUALIZATION EQUIPMENT 193
TABLE 91 OTHER VISUALIZATION EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 193
11.5 ENDOSCOPIC ACCESSORIES 193
11.5.1 GROWING NUMBER OF ENDOSCOPIC PROCEDURES TO PROPEL ADOPTION 193
TABLE 92 ENDOSCOPY ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 194
11.6 OTHER ENDOSCOPY EQUIPMENT 194
TABLE 93 OTHER ENDOSCOPY EQUIPMENT MARKET, BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 94 OTHER ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 195
11.6.1 ELECTRONIC ENDOSCOPY EQUIPMENT 195
11.6.1.1 Enable surgeons to perform procedures with ease 195
TABLE 95 ELECTRONIC ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 196
11.6.2 MECHANICAL ENDOSCOPY EQUIPMENT 196
11.6.2.1 Increasing number of endoscopy procedures to drive market 196
TABLE 96 MECHANICAL ENDOSCOPY EQUIPMENT MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 197
12 DIABETES CARE DEVICES MARKET 198
12.1 INTRODUCTION 199
12.2 MARKET DYNAMICS 199
FIGURE 31 DIABETES CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 199
12.2.1 DRIVERS 200
12.2.1.1 Global rise in diabetic population 200
12.2.1.2 Technological advancements in diabetes care devices 200
12.2.2 RESTRAINTS 200
12.2.2.1 High cost of devices and lack of reimbursement in developing countries 200
12.2.3 OPPORTUNITIES 201
12.2.3.1 Increasing diabetes-related health expenditure 201
12.2.4 CHALLENGES 201
12.2.4.1 Pricing pressure 201
TABLE 97 DIABETES CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 201
TABLE 98 DIABETES CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 202
12.3 BLOOD GLUCOSE MONITORING SYSTEMS 202
12.3.1 INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET 202
TABLE 99 BLOOD GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 203
12.4 INSULIN DELIVERY DEVICES 203
12.4.1 RISING AWARENESS OF DIABETES AND IMPROVING HEALTHCARE FACILITIES IN DEVELOPING COUNTRIES TO DRIVE MARKET 203
TABLE 100 INSULIN DELIVERY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 204
12.5 DIABETES MANAGEMENT MOBILE APPLICATIONS 204
12.5.1 GROWING ADOPTION OF BLOOD GLUCOSE TRACKING APPS TO SUPPORT MARKET GROWTH 204
TABLE 101 DIABETES MANAGEMENT MOBILE APPLICATIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 205
13 WOUND CARE DEVICES MARKET 206
13.1 INTRODUCTION 207
13.2 MARKET DYNAMICS 208
FIGURE 32 WOUND CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 208
13.2.1 DRIVERS 208
13.2.1.1 Growing prevalence of diseases and health conditions that affect wound healing capabilities 208
13.2.1.2 Technological advancements in wound care products 209
13.2.2 RESTRAINTS 209
13.2.2.1 Risks associated with use of advanced wound care products 209
TABLE 102 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS 209
13.2.3 OPPORTUNITIES 210
13.2.3.1 Growth potential of emerging countries 210
TABLE 103 STRATEGIC DEVELOPMENTS IN ASIA PACIFIC REGION 210
13.2.4 CHALLENGES 211
13.2.4.1 High cost of advanced wound care products 211
TABLE 104 AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS 211
TABLE 105 WOUND CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 211
TABLE 106 WOUND CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 212
13.3 ADVANCED WOUND CARE DEVICES 212
13.3.1 INCREASING INCIDENCE OF DIABETIC ULCERS TO PROPEL MARKET 212
TABLE 107 ADVANCED WOUND CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 213
13.4 SURGICAL WOUND CARE DEVICES 213
13.4.1 GROWING NUMBER OF SURGICAL PROCEDURES TO DRIVE MARKET 213
TABLE 108 SURGICAL WOUND CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 214
13.5 TRADITIONAL WOUND CARE DEVICES 214
13.5.1 RISING INCIDENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH 214
TABLE 109 TRADITIONAL WOUND CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 215
14 KIDNEY/DIALYSIS DEVICES MARKET 216
14.1 INTRODUCTION 217
14.2 MARKET DYNAMICS 217
FIGURE 33 KIDNEY/DIALYSIS DEVICES MARKET: DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 217
14.2.1 DRIVERS 218
14.2.1.1 Increasing number of ESRD patients 218
TABLE 110 NUMBER OF PEOPLE AGED 65 YEARS OR OVER, BY REGION, 2019 VS. 2050 218
14.2.1.2 Growing prevalence of diabetes and hypertension 218
14.2.2 RESTRAINTS 219
14.2.2.1 Risks and complications of dialysis 219
14.2.3 OPPORTUNITIES 219
14.2.3.1 Increasing number of dialysis centers 219
14.2.4 CHALLENGES 220
14.2.4.1 Benefits of renal transplantation 220
14.2.4.1.1 Low cost 220
14.2.4.1.2 Better survival rate 220
TABLE 111 KIDNEY/DIALYSIS DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 221
TABLE 112 KIDNEY/DIALYSIS DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 221
14.3 HEMODIALYSIS PRODUCTS 222
TABLE 113 HEMODIALYSIS PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 222
TABLE 114 HEMODIALYSIS PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 223
14.3.1 HEMODIALYSIS MACHINES 223
14.3.1.1 Presence of large ESRD patient population to drive market 223
TABLE 115 HEMODIALYSIS MACHINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 224
14.3.2 HEMODIALYSIS CONSUMABLES/SUPPLIES 224
14.3.2.1 Increasing number of ESRD patients to support market growth 224
TABLE 116 HEMODIALYSIS CONSUMABLES/SUPPLIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 225
14.4 PERITONEAL DIALYSIS PRODUCTS 225
TABLE 117 PERITONEAL DIALYSIS PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 226
TABLE 118 PERITONEAL DIALYSIS PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 226
14.4.1 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES 227
14.4.1.1 High demand for PD concentrates prompted players to focus on improving their manufacturing capabilities 227
TABLE 119 PERITONEAL DIALYSIS CONCENTRATES/DIALYSATES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 227
14.4.2 PERITONEAL DIALYSIS MACHINES 228
14.4.2.1 Rising prevalence of chronic diseases in emerging countries to boost adoption of home peritoneal dialysis 228
TABLE 120 PERITONEAL DIALYSIS MACHINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 229
14.4.3 PERITONEAL DIALYSIS CATHETERS 229
14.4.3.1 Favorable changes in reimbursement policies for PD catheters to support market growth 229
TABLE 121 PERITONEAL DIALYSIS CATHETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 230
14.4.4 PERITONEAL DIALYSIS TRANSFER SETS 230
14.4.4.1 Shift toward home dialysis to increase adoption of PD transfer sets 230
TABLE 122 PERITONEAL DIALYSIS TRANSFER SETS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 231
14.4.5 OTHER PERITONEAL DIALYSIS PRODUCTS 231
TABLE 123 OTHER PERITONEAL DIALYSIS PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 232
15 ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET 233
15.1 INTRODUCTION 234
15.2 MARKET DYNAMICS 234
FIGURE 34 RESPIRATORY CARE AND ANESTHESIA DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 234
15.2.1 DRIVERS 234
15.2.1.1 Rising prevalence of respiratory diseases 234
15.2.1.2 Increasing incidence of preterm births 235
15.2.2 RESTRAINTS 235
15.2.2.1 Unfavorable reimbursement scenario 235
15.2.3 OPPORTUNITIES 236
15.2.3.1 High growth in developing countries across Asia Pacific and Latin America 236
15.2.4 CHALLENGES 236
15.2.4.1 Harmful effects of certain devices on neonates 236
TABLE 124 ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 237
TABLE 125 ANESTHESIA AND RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 237
15.3 ANESTHESIA DEVICES 238
TABLE 126 ANESTHESIA DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 238
TABLE 127 ANESTHESIA DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 239
15.3.1 ANESTHESIA MACHINES 239
15.3.1.1 Demand for technologically advanced machines to propel market 239
TABLE 128 ANESTHESIA MACHINES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 240
15.3.2 ANESTHESIA DISPOSABLES 240
15.3.2.1 Increasing number of surgical procedures to support market growth 240
TABLE 129 ANESTHESIA DISPOSABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 241
15.4 RESPIRATORY CARE DEVICES 241
TABLE 130 RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 242
TABLE 131 RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 242
15.4.1 RESPIRATORY DEVICES 243
TABLE 132 RESPIRATORY DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 243
TABLE 133 RESPIRATORY DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 244
15.4.1.1 Humidifiers 244
15.4.1.1.1 Ensure optimum respiratory gas supply to ventilated patients 244
TABLE 134 HUMIDIFIERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 245
15.4.1.2 Nebulizers 245
15.4.1.2.1 Lower cost, ease of use, and long-term durability to support adoption 245
TABLE 135 NEBULIZERS AVAILABLE IN MARKET 246
TABLE 136 NEBULIZERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 247
15.4.1.3 Oxygen concentrators 247
15.4.1.3.1 Increasing incidence of respiratory diseases to drive market 247
TABLE 137 OXYGEN CONCENTRATORS AVAILABLE IN MARKET 248
TABLE 138 OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 249
15.4.1.4 PAP devices 249
15.4.1.4.1 Availability of reimbursement to favor market growth 249
TABLE 139 PAP DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 250
15.4.1.5 Reusable resuscitators 250
15.4.1.5.1 More economical in long run 250
TABLE 140 REUSABLE RESUSCITATORS OFFERED BY MAJOR PLAYERS 251
TABLE 141 REUSABLE RESUSCITATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 252
15.4.1.6 Ventilators 252
15.4.1.6.1 Increasing ICU admissions to support market growth 252
TABLE 142 VENTILATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 253
15.4.1.7 Inhalers 253
15.4.1.7.1 Widely used in treatment of major respiratory ailments 253
TABLE 143 INHALERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 254
15.4.2 RESPIRATORY DISPOSABLES 254
TABLE 144 RESPIRATORY DISPOSABLES MARKET, BY TYPE, 2020–2027 (USD MILLION) 254
TABLE 145 RESPIRATORY DISPOSABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 255
15.4.2.1 Disposable oxygen masks 255
15.4.2.1.1 Increasing patient population for respiratory diseases to drive adoption 255
TABLE 146 DISPOSABLE OXYGEN MASKS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 256
15.4.2.2 Resuscitators 256
15.4.2.2.1 Technological advancements to propel adoption 256
TABLE 147 RESUSCITATORS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 257
15.4.2.3 Tracheostomy tubes 257
15.4.2.3.1 Introduction of new and advanced products with ergonomic designs to drive market 257
TABLE 148 TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 258
15.4.2.4 Oxygen cannulas 258
15.4.2.4.1 Increasing demand for minimally invasive surgeries to boost demand 258
TABLE 149 OXYGEN CANNULAS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 259
15.4.3 RESPIRATORY MEASUREMENT DEVICES 259
TABLE 150 RESPIRATORY MEASUREMENT DEVICES MARKET, BY TYPE, 2020–2027 (USD MILLION) 260
TABLE 151 RESPIRATORY MEASUREMENT DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 260
15.4.3.1 Pulse oximetry systems 261
15.4.3.1.1 Rising adoption in home care settings to support market growth 261
TABLE 152 PULSE OXIMETER SYSTEMS OFFERED BY MAJOR PLAYERS 261
TABLE 153 PULSE OXIMETER SYSTEMS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 262
15.4.3.2 Capnographs 262
15.4.3.2.1 Extensive research to result in development of improved capnographs 262
TABLE 154 CAPNOGRAPHS OFFERED BY MAJOR PLAYERS 263
TABLE 155 CAPNOGRAPHS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 263
15.4.3.3 Spirometers 264
15.4.3.3.1 Technological advancements to increase adoption 264
TABLE 156 SPIROMETERS OFFERED BY MAJOR PLAYERS 265
TABLE 157 SPIROMETERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 265
15.4.3.4 Peak flow meters 266
15.4.3.4.1 Not preferred in hospitals due to high variability in measurements obtained 266
TABLE 158 PEAK FLOW METERS OFFERED BY VARIOUS PLAYERS 266
TABLE 159 PEAK FLOW METERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 267